These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. High rate of success in kidney cadaveric retransplantation with optimal matching and potent immunosuppression. Hiesse C; Neyrat N; Busson M; Bensadoun H; Lantz O; Bellamy J; Benoit G; Charpentier B; Fries D Transplant Proc; 1990 Aug; 22(4):1909-10. PubMed ID: 2389483 [No Abstract] [Full Text] [Related]
9. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience. Malinow L; Walker J; Klassen D; Oldach D; Schweitzer E; Bartlett ST; Weir MR Clin Transplant; 1996 Jun; 10(3):237-42. PubMed ID: 8826659 [TBL] [Abstract][Full Text] [Related]
10. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function. Venkat KK; Kupin W; Oh HK Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499 [No Abstract] [Full Text] [Related]
11. Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era. Hariharan S; Alexander JW; Schroeder TJ; First MR Clin Transplant; 1996 Apr; 10(2):186-90. PubMed ID: 8664516 [TBL] [Abstract][Full Text] [Related]
12. Improved cadaveric kidney graft survival with initiation of antilymphocyte globulin pretransplant in patients with a positive flow cytometry crossmatch. Hong JH; Sadeghian M; Sumrani N; Cacciarelli TV; Distant DA; Sommer BG; Norin AJ Transplant Proc; 1996 Jun; 28(3):1340-1. PubMed ID: 8658685 [No Abstract] [Full Text] [Related]
13. Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin. Fisher RA; Tchervenkov JI; Schroeder TJ; Alexander JW; Munda R; Penn I; Carey M; First MR Transplant Proc; 1991 Feb; 23(1 Pt 2):1253-5. PubMed ID: 1989203 [TBL] [Abstract][Full Text] [Related]
14. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation. Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109 [TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome. Koga A; Moreso FJ; Seron D; Gil-Vernet S; Cruzado JM; Castelao AM; Grinyó JM Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318 [TBL] [Abstract][Full Text] [Related]
16. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin. Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568 [TBL] [Abstract][Full Text] [Related]
18. Induction immunosuppression with antithymocyte globulin in renal transplantation using a variable dose according to the absolute number of CD3+ T cells. Abouna GM; Kumar MS; al-Abdullah IH; Loose J; Sullivan DK; Phillips K; Yost S; Seirka D Transplant Proc; 1995 Oct; 27(5):2676-8. PubMed ID: 7482872 [No Abstract] [Full Text] [Related]
19. Comparison of Minnesota antilymphocyte globulin and OKT3 for induction of immunosuppression in renal transplant patients. Light JA; Khawand N; Ali A; Brems W; Aquino A Transplant Proc; 1989 Feb; 21(1 Pt 2):1738-40. PubMed ID: 2652569 [TBL] [Abstract][Full Text] [Related]
20. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients. Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893 [No Abstract] [Full Text] [Related] [Next] [New Search]